お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
デフォルト表紙
市場調査レポート
商品コード
963120

医療情報 - 市場規模、シェア、動向分析:2020年~2027年

Medical Information Market Size, Share & Trends Analysis Report By Service Provider (In House, Outsourcing), By Therapeutic Area, By Product Life Cycle, By Company Size, By End-use, By Region, And Segment Forecasts, 2020 - 2027

出版日: | 発行: Grand View Research, Inc. | ページ情報: 英文 180 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.22円
医療情報 - 市場規模、シェア、動向分析:2020年~2027年
出版日: 2020年09月14日
発行: Grand View Research, Inc.
ページ情報: 英文 180 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の医療情報の市場規模は、2027年までに36億6000万米ドルに達し、予測期間中のCAGRで7.4%の成長が予測されています。技術的に高度なヘルスケアソリューションの出現と相まって、新薬開発の需要の増加、ヘルスケア製品に関連するタイムリーにアクセス可能な情報が、市場の成長を促進すると予想されます。

当レポートでは、世界の医療情報市場について調査分析し、市場概要、セグメント別の市場分析、競合情勢、主要企業などについて、体系的な情報を提供しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 医療情報市場の変数・動向・範囲

  • 医療情報市場力学
  • 規制の枠組み
  • 医療情報市場分析ツール:ポーターのファイブフォース分析
  • SWOT分析:要因別

第4章 価格分析

  • 組織構造のイントロダクション
  • 価格モデル

第5章 医療情報市場の新興動向

  • 人工知能、機械学習/オートメーション
  • ビッグデータ・アナリティクス
  • スピーチ・ビデオアナリティクス
  • IoT
  • クラウド
  • ブロックチェーン

第6章 医療情報市場:競合分析

  • イノベーター
  • 公開企業
    • 企業の市場シェア分析
    • ベンダー情勢
  • 主要な取引と買収

第7章 医療情報市場:サービスプロバイダー別の推定・動向分析

  • サービスプロバイダー別の市場シェア分析
  • サービスプロバイダー別のダッシュボード
    • インハウス
    • アウトソーシング

第8章 医療情報市場:治療分野別の推定・動向分析

  • 治療分野別の市場シェア分析
  • 治療分野別のダッシュボード
    • 腫瘍
    • 神経
    • 心臓病
    • 免疫
    • その他

第9章 医療情報市場:企業規模別の推定・動向分析

  • 企業規模別の市場シェア分析
  • 企業規模別のダッシュボード

第10章 医療情報市場:製品ライフサイクル別の推定・動向分析

  • 製品ライフサイクル別の市場シェア分析
  • 製品ライフサイクル別のダッシュボード
    • 前臨床
    • 臨床
    • 上市後の承認

第11章 医療情報市場:カテゴリー別の推定・動向分析

  • カテゴリー別の市場シェア分析
  • カテゴリー別のダッシュボード
    • 医薬品
    • バイオテクノロジー企業
    • 医療機器メーカー

第12章 医療情報市場:地域別の推定・動向分析、セグメント別

  • 地域別の市場スナップショット
  • 国別の市場シェア分析
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第13章 企業プロファイル

  • McKesson Corporation
  • Parexel International Corporation
  • IQVIA
  • C3i Solutions, HCL Technologies Company
  • PrimeVigilance
  • ProPharma Group
  • Accenture
  • Cognizant
  • Infosys Limited
  • PharmCentre

第14章 成功戦略

第15章 スイッチングコスト分析

第16章 COVID-19の影響分析

図表

List of Tables

  • TABLE 1 List of secondary sources
  • TABLE 2 Key leading market players anticipated to witness highest growth
  • TABLE 3 List of companies
  • TABLE 4 North America medical information market by service provider, 2016 - 2027 (USD Million)
  • TABLE 5 North America medical information market by therapeutic area, 2016 - 2027 (USD Million)
  • TABLE 6 North America medical information market by company size, 2016 - 2027 (USD Million)
  • TABLE 7 North America medical information market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 8 North America medical information market by end use, 2016 - 2027 (USD Million)
  • TABLE 9 North America pharmaceuticals market by category, 2016 - 2027 (USD Million)
  • TABLE 10 North America innovators market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 11 North America generics market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 12 North America biotechnology companies' market by category, 2016 - 2027 (USD Million)
  • TABLE 13 North America biologics market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 14 North America ATMPs market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 15 North America biosimilars market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 16 North America medical device manufacturers market by category, 2016 - 2027 (USD Million)
  • TABLE 17 North America diagnostic medical device manufacturers market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 18 North America therapeutic medical devices manufacturers market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 19 The U.S. medical information market by service provider, 2016 - 2027 (USD Million)
  • TABLE 20 The U.S. medical information market by therapeutic area, 2016 - 2027 (USD Million)
  • TABLE 21 The U.S. medical information market by company size, 2016 - 2027 (USD Million)
  • TABLE 22 The U.S. medical information market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 23 The U.S. medical information market by end use, 2016 - 2027 (USD Million)
  • TABLE 24 The U.S. pharmaceuticals market by category, 2016 - 2027 (USD Million)
  • TABLE 25 The U.S. innovators market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 26 The U.S. generics market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 27 The U.S. biotechnology companies' market by category, 2016 - 2027 (USD Million)
  • TABLE 28 The U.S. biologics market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 29 The U.S. ATMPs market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 30 The U.S. biosimilars market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 31 The U.S. medical device manufacturers market by category, 2016 - 2027 (USD Million)
  • TABLE 32 The U.S. diagnostic medical device manufacturers market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 33 The U.S. therapeutic medical devices manufacturers market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 34 Canada medical information market by service provider, 2016 - 2027 (USD Million)
  • TABLE 35 Canada medical information market by therapeutic area, 2016 - 2027 (USD Million)
  • TABLE 36 Canada medical information market by company size, 2016 - 2027 (USD Million)
  • TABLE 37 Canada medical information market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 38 Canada medical information market by end use, 2016 - 2027 (USD Million)
  • TABLE 39 Canada pharmaceuticals market by category, 2016 - 2027 (USD Million)
  • TABLE 40 Canada innovators market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 41 Canada generics market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 42 Canada biotechnology companies' market by category, 2016 - 2027 (USD Million)
  • TABLE 43 Canada biologics market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 44 Canada ATMPs market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 45 Canada biosimilars market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 46 Canada medical device manufacturers market by category, 2016 - 2027 (USD Million)
  • TABLE 47 Canada diagnostic medical device manufacturers market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 48 Canada therapeutic medical devices manufacturers market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 49 Europe medical information market by service provider, 2016 - 2027 (USD Million)
  • TABLE 50 Europe medical information market by therapeutic area, 2016 - 2027 (USD Million)
  • TABLE 51 Europe medical information market by company size, 2016 - 2027 (USD Million)
  • TABLE 52 Europe. medical information market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 53 Europe medical information market by end use, 2016 - 2027 (USD Million)
  • TABLE 54 Europe pharmaceuticals market by category, 2016 - 2027 (USD Million)
  • TABLE 55 Europe innovators market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 56 Europe generics market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 57 Europe biotechnology companies' market by category, 2016 - 2027 (USD Million)
  • TABLE 58 Europe biologics market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 59 Europe ATMPs market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 60 Europe biosimilars market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 61 Europe medical device manufacturers market by category, 2016 - 2027 (USD Million)
  • TABLE 62 Europe diagnostic medical device manufacturers market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 63 Europe therapeutic medical devices manufacturers market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 64 The U.K. medical information market by service provider, 2016 - 2027 (USD Million)
  • TABLE 65 The U.K. medical information market by therapeutic area, 2016 - 2027 (USD Million)
  • TABLE 66 The U.K. medical information market by company size, 2016 - 2027 (USD Million)
  • TABLE 67 The U.K. medical information market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 68 The U.K. medical information market by end use, 2016 - 2027 (USD Million)
  • TABLE 69 The U.K. pharmaceuticals market by category, 2016 - 2027 (USD Million)
  • TABLE 70 The U.K. innovators market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 71 The U.K. generics market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 72 The U.K. biotechnology companies' market by category, 2016 - 2027 (USD Million)
  • TABLE 73 The U.K. biologics market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 74 The U.K. ATMPs market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 75 The U.K. biosimilars market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 76 The U.K. medical device manufacturers market by category, 2016 - 2027 (USD Million)
  • TABLE 77 The U.K. diagnostic medical device manufacturers market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 78 The U.K. therapeutic medical devices manufacturers market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 79 Germany medical information market by service provider, 2016 - 2027 (USD Million)
  • TABLE 80 Germany medical information market by therapeutic area, 2016 - 2027 (USD Million)
  • TABLE 81 Germany medical information market by company size, 2016 - 2027 (USD Million)
  • TABLE 82 Germany medical information market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 83 Germany medical information market by end use, 2016 - 2027 (USD Million)
  • TABLE 84 Germany pharmaceuticals market by category, 2016 - 2027 (USD Million)
  • TABLE 85 Germany innovators market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 86 Germany generics market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 87 Germany biotechnology companies' market by category, 2016 - 2027 (USD Million)
  • TABLE 88 Germany biologics market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 89 Germany ATMPs market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 90 Germany biosimilars market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 91 Germany medical device manufacturers market by category, 2016 - 2027 (USD Million)
  • TABLE 92 Germany diagnostic medical device manufacturers market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 93 Germany therapeutic medical devices manufacturers market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 94 France medical information market by service provider, 2016 - 2027 (USD Million)
  • TABLE 95 France medical information market by therapeutic area, 2016 - 2027 (USD Million)
  • TABLE 96 France medical information market by company size, 2016 - 2027 (USD Million)
  • TABLE 97 France medical information market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 98 France medical information market by end use, 2016 - 2027 (USD Million)
  • TABLE 99 France pharmaceuticals market by category, 2016 - 2027 (USD Million)
  • TABLE 100 France innovators market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 101 France generics market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 102 France biotechnology companies' market by category, 2016 - 2027 (USD Million)
  • TABLE 103 France biologics market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 104 France ATMPs market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 105 France biosimilars market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 106 France medical device manufacturers market by category, 2016 - 2027 (USD Million)
  • TABLE 107 France diagnostic medical device manufacturers market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 108 France therapeutic medical devices manufacturers market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 109 Italy medical information market by service provider, 2016 - 2027 (USD Million)
  • TABLE 110 Italy medical information market by therapeutic area, 2016 - 2027 (USD Million)
  • TABLE 111 Italy medical information market by company size, 2016 - 2027 (USD Million)
  • TABLE 112 Italy medical information market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 113 Italy medical information market by end use, 2016 - 2027 (USD Million)
  • TABLE 114 Italy pharmaceuticals market by category, 2016 - 2027 (USD Million)
  • TABLE 115 Italy innovators market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 116 Italy generics market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 117 Italy biotechnology companies' market by category, 2016 - 2027 (USD Million)
  • TABLE 118 Italy biologics market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 119 Italy ATMPs market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 120 Italy biosimilars market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 121 Italy medical device manufacturers market by category, 2016 - 2027 (USD Million)
  • TABLE 122 Italy diagnostic medical device manufacturers market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 123 Italy therapeutic medical devices manufacturers market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 124 Spain medical information market by service provider, 2016 - 2027 (USD Million)
  • TABLE 125 Spain medical information market by therapeutic area, 2016 - 2027 (USD Million)
  • TABLE 126 Spain medical information market by company size, 2016 - 2027 (USD Million)
  • TABLE 127 Spain medical information market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 128 Spain medical information market by end use, 2016 - 2027 (USD Million)
  • TABLE 129 Spain pharmaceuticals market by category, 2016 - 2027 (USD Million)
  • TABLE 130 Spain innovators market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 131 Spain generics market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 132 Spain biotechnology companies' market by category, 2016 - 2027 (USD Million)
  • TABLE 133 Spain biologics market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 134 Spain ATMPs market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 135 Spain biosimilars market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 136 Spain medical device manufacturers market by category, 2016 - 2027 (USD Million)
  • TABLE 137 Spain diagnostic medical device manufacturers market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 138 Spain therapeutic medical devices manufacturers market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 139 Asia Pacific medical information market by service provider, 2016 - 2027 (USD Million)
  • TABLE 140 Asia Pacific medical information market by therapeutic area, 2016 - 2027 (USD Million)
  • TABLE 141 Asia Pacific medical information market by company size, 2016 - 2027 (USD Million)
  • TABLE 142 Asia Pacific medical information market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 143 Asia Pacific medical information market by end use, 2016 - 2027 (USD Million)
  • TABLE 144 Asia Pacific pharmaceuticals market by category, 2016 - 2027 (USD Million)
  • TABLE 145 Asia Pacific innovators market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 146 Asia Pacific generics market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 147 Asia Pacific biotechnology companies' market by category, 2016 - 2027 (USD Million)
  • TABLE 148 Asia Pacific biologics market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 149 Asia Pacific ATMPs market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 150 Asia Pacific biosimilars market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 151 Asia Pacific medical device manufacturers market by category, 2016 - 2027 (USD Million)
  • TABLE 152 Asia Pacific diagnostic medical device manufacturers market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 153 Asia Pacific therapeutic medical devices manufacturers market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 154 Japan medical information market by service provider, 2016 - 2027 (USD Million)
  • TABLE 155 Japan medical information market by therapeutic area, 2016 - 2027 (USD Million)
  • TABLE 156 Japan medical information market by company size, 2016 - 2027 (USD Million)
  • TABLE 157 Japan medical information market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 158 Japan medical information market by end use, 2016 - 2027 (USD Million)
  • TABLE 159 Japan pharmaceuticals market by category, 2016 - 2027 (USD Million)
  • TABLE 160 Japan innovators market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 161 Japan generics market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 162 Japan biotechnology companies' market by category, 2016 - 2027 (USD Million)
  • TABLE 163 Japan biologics market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 164 Japan ATMPs market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 165 Japan biosimilars market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 166 Japan medical device manufacturers market by category, 2016 - 2027 (USD Million)
  • TABLE 167 Japan diagnostic medical device manufacturers market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 168 Japan therapeutic medical devices manufacturers market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 169 China medical information market by service provider, 2016 - 2027 (USD Million)
  • TABLE 170 China medical information market by therapeutic area, 2016 - 2027 (USD Million)
  • TABLE 171 China medical information market by company size, 2016 - 2027 (USD Million)
  • TABLE 172 China medical information market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 173 China medical information market by end use, 2016 - 2027 (USD Million)
  • TABLE 174 China pharmaceuticals market by category, 2016 - 2027 (USD Million)
  • TABLE 175 China innovators market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 176 China generics market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 177 China biotechnology companies' market by category, 2016 - 2027 (USD Million)
  • TABLE 178 China biologics market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 179 China ATMPs market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 180 China biosimilars market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 181 China medical device manufacturers market by category, 2016 - 2027 (USD Million)
  • TABLE 182 China diagnostic medical device manufacturers market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 183 China therapeutic medical devices manufacturers market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 184 India medical information market by service provider, 2016 - 2027 (USD Million)
  • TABLE 185 India medical information market by therapeutic area, 2016 - 2027 (USD Million)
  • TABLE 186 India medical information market by company size, 2016 - 2027 (USD Million)
  • TABLE 187 India medical information market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 188 India medical information market by end use, 2016 - 2027 (USD Million)
  • TABLE 189 India pharmaceuticals market by category, 2016 - 2027 (USD Million)
  • TABLE 190 India innovators market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 191 India generics market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 192 India biotechnology companies' market by category, 2016 - 2027 (USD Million)
  • TABLE 193 India biologics market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 194 India ATMPs market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 195 India biosimilars market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 196 India medical device manufacturers market by category, 2016 - 2027 (USD Million)
  • TABLE 197 India diagnostic medical device manufacturers market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 198 India therapeutic medical devices manufacturers market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 199 Latin America medical information market by service provider, 2016 - 2027 (USD Million)
  • TABLE 200 Latin America medical information market by therapeutic area, 2016 - 2027 (USD Million)
  • TABLE 201 Latin America medical information market by company size, 2016 - 2027 (USD Million)
  • TABLE 202 Latin America medical information market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 203 Latin America medical information market by end use, 2016 - 2027 (USD Million)
  • TABLE 204 Latin America pharmaceuticals market by category, 2016 - 2027 (USD Million)
  • TABLE 205 Latin America innovators market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 206 Latin America generics market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 207 Latin America biotechnology companies' market by category, 2016 - 2027 (USD Million)
  • TABLE 208 Latin America biologics market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 209 Latin America ATMPs market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 210 Latin America biosimilars market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 211 Latin America medical device manufacturers market by category, 2016 - 2027 (USD Million)
  • TABLE 212 Latin America diagnostic medical device manufacturers market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 213 Latin America therapeutic medical devices manufacturers market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 214 Brazil medical information market by service provider, 2016 - 2027 (USD Million)
  • TABLE 215 Brazil medical information market by therapeutic area, 2016 - 2027 (USD Million)
  • TABLE 216 Brazil medical information market by company size, 2016 - 2027 (USD Million)
  • TABLE 217 Brazil medical information market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 218 Brazil medical information market by end use, 2016 - 2027 (USD Million)
  • TABLE 219 Brazil pharmaceuticals market by category, 2016 - 2027 (USD Million)
  • TABLE 220 Brazil innovators market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 221 Brazil generics market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 222 Brazil biotechnology companies' market by category, 2016 - 2027 (USD Million)
  • TABLE 223 Brazil biologics market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 224 Brazil ATMPs market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 225 Brazil biosimilars market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 226 Brazil medical device manufacturers market by category, 2016 - 2027 (USD Million)
  • TABLE 227 Brazil diagnostic medical device manufacturers market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 228 Brazil therapeutic medical devices manufacturers market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 229 Mexico medical information market by service provider, 2016 - 2027 (USD Million)
  • TABLE 230 Mexico medical information market by therapeutic area, 2016 - 2027 (USD Million)
  • TABLE 231 Mexico medical information market by company size, 2016 - 2027 (USD Million)
  • TABLE 232 Mexico medical information market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 233 Mexico medical information market by end use, 2016 - 2027 (USD Million)
  • TABLE 234 Mexico pharmaceuticals market by category, 2016 - 2027 (USD Million)
  • TABLE 235 Mexico innovators market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 236 Mexico generics market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 237 Mexico biotechnology companies' market by category, 2016 - 2027 (USD Million)
  • TABLE 238 Mexico biologics market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 239 Mexico ATMPs market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 240 Mexico biosimilars market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 241 Mexico medical device manufacturers market by category, 2016 - 2027 (USD Million)
  • TABLE 242 Mexico diagnostic medical device manufacturers market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 243 Mexico therapeutic medical devices manufacturers market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 244 MEA medical information market by service provider, 2016 - 2027 (USD Million)
  • TABLE 245 MEA medical information market by therapeutic area, 2016 - 2027 (USD Million)
  • TABLE 246 MEA medical information market by company size, 2016 - 2027 (USD Million)
  • TABLE 247 MEA medical information market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 248 MEA medical information market by end use, 2016 - 2027 (USD Million)
  • TABLE 249 MEA pharmaceuticals market by category, 2016 - 2027 (USD Million)
  • TABLE 250 MEA innovators market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 251 MEA generics market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 252 MEA biotechnology companies' market by category, 2016 - 2027 (USD Million)
  • TABLE 253 MEA biologics market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 254 MEA ATMPs market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 255 MEA biosimilars market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 256 MEA medical device manufacturers market by category, 2016 - 2027 (USD Million)
  • TABLE 257 MEA diagnostic medical device manufacturers market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 258 MEA therapeutic medical devices manufacturers market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 259 South Africa medical information market by service provider, 2016 - 2027 (USD Million)
  • TABLE 260 South Africa medical information market by therapeutic area, 2016 - 2027 (USD Million)
  • TABLE 261 South Africa medical information market by company size, 2016 - 2027 (USD Million)
  • TABLE 262 South Africa medical information market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 263 South Africa medical information market by end use, 2016 - 2027 (USD Million)
  • TABLE 264 South Africa pharmaceuticals market by category, 2016 - 2027 (USD Million)
  • TABLE 265 South Africa innovators market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 266 South Africa generics market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 267 South Africa biotechnology companies' market by category, 2016 - 2027 (USD Million)
  • TABLE 268 South Africa biologics market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 269 South Africa ATMPs market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 270 South Africa biosimilars market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 271 South Africa medical device manufacturers market by category, 2016 - 2027 (USD Million)
  • TABLE 272 South Africa diagnostic medical device manufacturers market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 273 South Africa therapeutic medical devices manufacturers market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 274 KSA medical information market by service provider, 2016 - 2027 (USD Million)
  • TABLE 275 KSA medical information market by therapeutic area, 2016 - 2027 (USD Million)
  • TABLE 276 KSA medical information market by company size, 2016 - 2027 (USD Million)
  • TABLE 277 KSA medical information market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 278 KSA medical information market by end use, 2016 - 2027 (USD Million)
  • TABLE 279 KSA pharmaceuticals market by category, 2016 - 2027 (USD Million)
  • TABLE 280 KSA innovators market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 281 KSA generics market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 282 KSA biotechnology companies' market by category, 2016 - 2027 (USD Million)
  • TABLE 283 KSA biologics market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 284 KSA ATMPs market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 285 KSA biosimilars market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 286 KSA medical device manufacturers market by category, 2016 - 2027 (USD Million)
  • TABLE 287 KSA diagnostic medical device manufacturers market by product life cycle, 2016 - 2027 (USD Million)
  • TABLE 288 KSA therapeutic medical devices manufacturers market by product life cycle, 2016 - 2027 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews breakdown
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Medical information market snapshot, 2019 (USD Million)
  • Fig. 10 Medical information market dynamics
  • Fig. 11 Medical information market driver impact
  • Fig. 12 Medical information Services FTE Adoption
  • Fig. 13 Medical information market restraint impact
  • Fig. 14 Medical information process
  • Fig. 15 MI structure
  • Fig. 16 MI organization structure
  • Fig. 17 Estimated budget allocation of medical affairs activities at global level, 2019
  • Fig. 18 Activities performed by Mi call centers 2019, estimated
  • Fig. 19 Average % of drug safety budget contributed by function at global level
  • Fig. 20 Estimated company market share analysis, 2019 (%)
  • Fig. 21 Medical information market: Service provider movement analysis
  • Fig. 22 Medical information Service provider dashboard
  • Fig. 23 Global In-house market, 2016 - 2027 (USD Million)
  • Fig. 24 Global contract outsourcing market, 2016 - 2027 (USD Million)
  • Fig. 25 Medical information market: Therapeutic area movement analysis
  • Fig. 26 Medical information market therapeutic area dashboard
  • Fig. 27 Global oncology market, 2016 - 2027 (USD Million)
  • Fig. 28 Global neurology market, 2016 - 2027 (USD Million)
  • Fig. 29 Global cardiology market, 2016 - 2027 (USD Million)
  • Fig. 30 Global immunology market, 2016 - 2027 (USD Million)
  • Fig. 31 Global others market, 2016 - 2027 (USD Million)
  • Fig. 32 Medical information market: Company size movement analysis
  • Fig. 33 Medical information company size dashboard
  • Fig. 34 Global small companies' market, 2016 - 2027 (USD Million)
  • Fig. 35 Global medium-sized companies market, 2016 - 2027 (USD Million)
  • Fig. 36 Global large scale companies market, 2016 - 2027 (USD Million)
  • Fig. 37 Medical information market: Product life cycle movement analysis
  • Fig. 38 Medical information market product life cycle dashboard
  • Fig. 39 Global Preclinical market, 2016 - 2027 (USD Million)
  • Fig. 40 Global clinical market, 2016 - 2027 (USD Million)
  • Fig. 41 Global PMA market, 2016 - 2027 (USD Million)
  • Fig. 42 Medical information market: Category movement analysis
  • Fig. 43 Medical information market category dashboard
  • Fig. 44 Global pharmaceuticals market, 2016 - 2027 (USD Million)
  • Fig. 45 Global innovators market, 2016 - 2027 (USD Million)
  • Fig. 46 Global pre-clinical market, 2016 - 2027 (USD Million)
  • Fig. 47 Global Clinical market, 2016 - 2027 (USD Million)
  • Fig. 48 Global PMA market, 2016 - 2027 (USD Million)
  • Fig. 49 Global Generics market, 2016 - 2027 (USD Million)
  • Fig. 50 Global pre-clinical market, 2016 - 2027 (USD Million)
  • Fig. 51 Global clinical market, 2016 - 2027 (USD Million)
  • Fig. 52 Global PMA market, 2016 - 2027 (USD Million)
  • Fig. 53 Global Biotechnology companies market, 2016 - 2027 (USD Million)
  • Fig. 54 Global biologics market, 2016 - 2027 (USD Million)
  • Fig. 55 Global pre-clinical market, 2016 - 2027 (USD Million)
  • Fig. 56 Global clinical market, 2016 - 2027 (USD Million)
  • Fig. 57 Global PMA market, 2016 - 2027 (USD Million)
  • Fig. 58 Global ATMPs market, 2016 - 2027 (USD Million)
  • Fig. 59 Global pre-clinical market, 2016 - 2027 (USD Million)
  • Fig. 60 Global clinical market, 2016 - 2027 (USD Million)
  • Fig. 61 Global PMA market, 2016 - 2027 (USD Million)
  • Fig. 62 Global biosimilar market, 2016 - 2027 (USD Million)
  • Fig. 63 Global pre-clinical market, 2016 - 2027 (USD Million)
  • Fig. 64 Global clinical market, 2016 - 2027 (USD Million)
  • Fig. 65 Global PMA market, 2016 - 2027 (USD Million)
  • Fig. 66 Global medical device manufacturers market, 2016 - 2027 (USD Million)
  • Fig. 67 Global therapeutic medical devices market, 2016 - 2027 (USD Million)
  • Fig. 68 Global pre-clinical market, 2016 - 2027 (USD Million)
  • Fig. 69 Global clinical market, 2016 - 2027 (USD Million)
  • Fig. 70 Global PMA market, 2016 - 2027 (USD Million)
  • Fig. 71 Global diagnostic medical devices market, 2016 - 2027 (USD Million)
  • Fig. 72 Global pre-clinical market, 2016 - 2027 (USD Million)
  • Fig. 73 Global clinical market, 2016 - 2027 (USD Million)
  • Fig. 74 Global PMA market, 2016 - 2027 (USD Million)
  • Fig. 75 Regional market place: Key takeaways
  • Fig. 76 North America medical information market share by countries, 2019
  • Fig. 77 Europe medical information market share by countries, 2019
  • Fig. 78 Asia Pacific medical information market share by countries, 2019
  • Fig. 79 Latin America medical information market share by countries, 2019
  • Fig. 80 MEA medical information market share by countries, 2019
  • Fig. 81 Regional outlook, 2019 & 2027
  • Fig. 82 North America medical information market, 2016 - 2027 (USD Million)
  • Fig. 83 The U.S. medical information market, 2016 - 2027 (USD Million)
  • Fig. 84 Canada medical information market, 2016 - 2027 (USD Million)
  • Fig. 85 Europe medical information market, 2016 - 2027 (USD Million)
  • Fig. 86 The U.K. medical information market, 2016 - 2027 (USD Million)
  • Fig. 87 Germany medical information market, 2016 - 2027 (USD Million)
  • Fig. 88 France medical information market, 2016 - 2027 (USD Million)
  • Fig. 89 Italy medical information market, 2016 - 2027 (USD Million)
  • Fig. 90 Spain medical information market, 2016 - 2027 (USD Million)
  • Fig. 91 Asia Pacific Medical information market, 2016 - 2027 (USD Million)
  • Fig. 92 Japan medical information market, 2016 - 2027 (USD Million)
  • Fig. 93 China medical information market, 2016 - 2027 (USD Million)
  • Fig. 94 India medical information market, 2016 - 2027 (USD Million)
  • Fig. 95 Latin America medical information market, 2016 - 2027 (USD Million)
  • Fig. 96 Brazil medical information market, 2016 - 2027 (USD Million)
  • Fig. 97 Mexico medical information market, 2016 - 2027 (USD Million)
  • Fig. 98 MEA medical information market, 2016 - 2027 (USD Million)
  • Fig. 99 South Africa medical information market, 2016 - 2027 (USD Million)
  • Fig. 100 Saudi Arabia medical information market, 2016 - 2027 (USD Million)
  • Fig. 101 Organization Structure - McKesson Corporation
  • Fig. 102 SWOT - McKesson Corporation
  • Fig. 103 Organization Structure - Parexel International Corporation
  • Fig. 104 SWOT - Parexel International Corporation
  • Fig. 105 Organization Structure - IQVIA
  • Fig. 106 SWOT - IQVIA
  • Fig. 107 Organization Structure - C3i Solutions
  • Fig. 108 SWOT - C3i Solutions
  • Fig. 109 Organization Structure - PrimeVigilance
  • Fig. 110 SWOT - PrimeVigilance
  • Fig. 111 Organization Structure - ProPharma
  • Fig. 112 SWOT - ProPharma
  • Fig. 113 Organization Structure - Accenture
  • Fig. 114 SWOT - Accenture
  • Fig. 115 Organization Structure - Cognizant
  • Fig. 116 SWOT - Cognizant
  • Fig. 117 Organization Structure - Infosys
  • Fig. 118 SWOT - Infosys
  • Fig. 119 Organization Structure - PharmCentrre
  • Fig. 120 SWOT - PharmCentre
  • Fig. 121 Vendor selection criteria
  • Fig. 122 Reasons for switching the service provider
目次
Product Code: GVR-4-68039-122-8

Medical Information Market Growth & Trends

The global medical information market size is expected to reach USD 3.66 Billion by 2027, according to a new report by Grand View Research, Inc. The market is projected to progress at a CAGR of 7.4% during the forecast period. Increasing demand for new drug development coupled with the emergence of technologically advanced healthcare solutions, timely accessible information pertinent to healthcare products is anticipated to fuel the market growth.

Increasing healthcare expenditure and growing awareness about adverse drug events can increase the possibility of patients seeking medical information. Increase in adoption of social media for discussions on adverse events, ingredients, and other drug-related information.

The market expansion is a result of an increased number of clinical trials and due to the high prevalence of chronic diseases. Moreover, manufacturers of health products are outsourcing MI services to Contract Research Organizations (CROs) to limit the accountability of stringent regulatory compliances by working with a well-established outsourcing partner company. This helps them in reducing operational costs, regulatory compliance risk, and minimizing process delays.

The key factors attributing to the increased demand for outsourcing of medical information services are rising costs of pre-clinical research, drug development, clinical trials, and post-marketing surveillance. The healthcare sector is witnessing paradigm changes in the past decade, due to the depleting product pipeline, patent cliff, and regulatory constraints in new product development. This is expected to boost the adoption of contract outsourcing activities over the forecast period.

Rising drug development cost, high investments needed for drug discovery, clinical research, and post-marketing surveillance are some of the key contributors to the market growth. The medical sector is witnessing paradigm shifts over the last decade, owing to an increasing number of patent cliffs, regulatory constraints, and the depleting product pipeline.

Medical Information Market Report Highlights

The contract outsourcing segment is anticipated to witness a lucrative CAGR of around 8.8% from 2020 to 2027 owing to the increasing number of manufactures opt for outsourcing their MI management activities to third party vendors in order to improve the return on investment, maintain product quality and cost, profitability, and to achieve capacity restrictions.

Based on the therapeutic area, the immunology segment is projected to ascend at a revenue-based CAGR of 9.0% over the forecast period

The clinical trial phase segment dominated the market with a revenue share of 47.0% in 2019, owing to the increasing number of clinical trials and pressure from regulatory bodies to meet standards and compliances

The medium-sized companies' segment is projected to expand at a CAGR of 7.7% to reach the value of USD 1.76 billion by 2027

By end-use, biotechnology companies are anticipated to witness the fastest CAGR of around 8.1% over the forecast period. The increasing number of biologics in the market and a strong pipeline for innovative products are key attributing factors towards this segment's growth

Asia Pacific is projected to showcase a considerable CAGR of around 7.9% due to the presence of a large number of outsourcing organizations. Consequentially, there is improved productivity, cost-efficiency, and resource sharing, which is further anticipated to propel demand

India and China are the key hubs for the life sciences outsourcing market. The abundant availability of low-cost and high-skilled labor, land, and other resources in this region provides a competitive advantage in terms of production costs and the back-end processing of several services

The medical information industry is highly competitive and diverse with many numbers of the small, medium, and large scale enterprises vying for the market share

Collaboration with CROs provides access to cutting-edge services, therefore, manufacturers, government organizations prefer assigning projects to them. This is expected to propel the demand for outsourcing MI services in coming years

Table of Contents

Chapter 1 Research Methodology & Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Service Provider
    • 1.1.2 TherapeutiC area
    • 1.1.3 Company Size
    • 1.1.4 Product Life Cycle
    • 1.1.5 Category
    • 1.1.6 Regional Scope
    • 1.1.7 Estimates and Forecast Timeline
  • 1.2 Market Definitions
    • 1.2.1 Medical Information
  • 1.3 Research Methodology
  • 1.4 Information Procurement
    • 1.4.1 Purchased database:
    • 1.4.2 GVR's Internal Database
    • 1.4.3 Secondary sources
    • 1.4.4 Primary Research:
    • 1.4.5 Details of Primary Research
      • 1.4.5.1 Data for primary interviews
  • 1.5 Information or Data Analysis
    • 1.5.1 Data Analysis Models
  • 1.6 Market Formulation & Validation
  • 1.7 Model Details
    • 1.7.1 Commodity Flow Analysis (Model 1)
  • 1.8 List of Secondary Sources
  • 1.9 Report Objectives
    • 1.9.1 Objective 1:
    • 1.9.2 Objective 2:

Chapter 2 Executive Summary

  • 2.1 Market Outlook

Chapter 3 Medical Information Market Variables, Trends & Scope

  • 3.1 Medical Information Market Dynamics
    • 3.1.1 Market driver analysis
      • 3.1.1.1 strategic initiatives by market players
      • 3.1.1.2 increasing Adoption of artificial intelligence followed by growing demand for healthcare information systems in the healthcare organizations
      • 3.1.1.3 outsourcing of medical information services
    • 3.1.2 Market restraint analysis
      • 3.1.2.1 data security and privacy concerns
      • 3.1.2.2 issues with interoperability and high cost of integration
  • 3.2 Regulatory Framework
    • 3.2.1 Standard & Compliance
  • 3.3 Medical information Market Analysis Tools: Porters
    • 3.3.1 Bargaining Power of Suppliers
    • 3.3.2 Bargaining Power of Buyers
    • 3.3.3 Threat of Substitutes
    • 3.3.4 Threat of New Entrants
    • 3.3.5 Industry Rivalry
  • 3.4 SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
    • 3.4.1 Political & Legal
    • 3.4.2 Economic
    • 3.4.3 Technological & Social

Chapter 4 Pricing Analysis

  • 4.1 Organization Structure Introduction
  • 4.2 Pricing Models
    • 4.2.1 MedicAL Affairs Budget allocation by activities
    • 4.2.2 Pricing Level
      • 4.2.2.1 Medical writing

Chapter 5 Emerging Trends in Medical Information Market

  • 5.1 Artificial Intelligence, Machine Learning/Automation
  • 5.2 Big Data and Analytics
  • 5.3 Speech & Video Analytics
  • 5.4 IoT
  • 5.5 Cloud
  • 5.6 Blockchain

Chapter 6 Medical Information Market: Competitive Analysis

  • 6.1 Innovators
  • 6.2 Public Companies
    • 6.2.1 Company market share analysis
    • 6.2.2 Vendor Landscape
  • 6.3 Major Deals & Acquisitions

Chapter 7 Medical Information Market: Service Provider Estimates & Trend Analysis

  • 7.1 Service Provider Market Share Analysis, 2019 & 2027
  • 7.2 Service Provider Dashboard
    • 7.2.1 In House
      • 7.2.1.1 In house market estimates and forecasts, 2016 - 2027 (USD Million)
    • 7.2.2 Contract Outsourcing
      • 7.2.2.1 Contract outsourcing market estimates and forecasts, 2016 - 2027 (USD Million)

Chapter 8 Medical Information Market: Therapeutic Area Estimates & Trend Analysis

  • 8.1 Therapeutic Area Market Share Analysis, 2019 & 2027
  • 8.2 Therapeutic Area Dashboard
    • 8.2.1 Oncology
      • 8.2.1.1 Oncology market estimates and forecasts, 2016 - 2027 (USD Million)
    • 8.2.2 Neurology
      • 8.2.2.1 Neurology market estimates and forecasts, 2016 - 2027 (USD Million)
    • 8.2.3 Cardiology
      • 8.2.3.1 Cardiology market estimates and forecasts, 2016 - 2027 (USD Million)
    • 8.2.4 Immunology
      • 8.2.4.1 Immunology market estimates and forecasts, 2016 - 2027 (USD Million)
    • 8.2.5 Others
      • 8.2.5.1 Others market estimates and forecasts, 2016 - 2027 (USD Million)

Chapter 9 Medical Information Market: Company size Estimates & Trend Analysis

  • 9.1 Company Size Market Share Analysis, 2019 & 2027
  • 9.2 Company Size Dashboard
    • 9.2.1 Small
      • 9.2.1.1 Small market estimates and forecasts, 2016 - 2027 (USD Million)
    • 9.2.2 Medium
      • 9.2.2.1 Medium market estimates and forecasts, 2016 - 2027 (USD Million)
    • 9.2.3 Large Scale
      • 9.2.3.1 Large Scalemarket estimates and forecasts, 2016 - 2027 (USD Million)

Chapter 10 Medical information Market: Product Life Cycle Estimates & Trend Analysis

  • 10.1 Product Life Cycle Market Share Analysis, 2019 & 2027
  • 10.2 Product Life Cycle Dashboard
    • 10.2.1 Preclinical
      • 10.2.1.1 Preclinical market estimates and forecasts, 2016 - 2027 (USD Million)
    • 10.2.2 Clinical
      • 10.2.2.1 Clinical market estimates and forecasts, 2016 - 2027 (USD Million)
    • 10.2.3 Post Market Approval
      • 10.2.3.1 PMA market estimates and forecasts, 2016 - 2027 (USD Million)

Chapter 11 Medical Information Market: Category Estimates & Trend Analysis

  • 11.1 Category Market Share Analysis, 2019 & 2027
  • 11.2 Category Dashboard
    • 11.2.1 Pharmaceuticals
      • 11.2.1.1 Pharmaceuticals market estimates and forecasts, 2016 - 2027 (USD Million)
      • 11.2.1.2 Innovators
      • 11.2.1.2.1 Innovators market estimates and forecasts, 2016 - 2027 (USD Million)
      • 11.2.1.2.2 Pre-clinical
      • 11.2.1.2.2.1 Pre-clinical market estimates and forecasts, 2016 - 2027 (USD Million)
      • 11.2.1.2.3 Clinical
      • 11.2.1.2.3.1 Clinical market estimates and forecasts, 2016 - 2027 (USD Million)
      • 11.2.1.2.4 PMA
      • 11.2.1.2.4.1 PMA market estimates and forecasts, 2016 - 2027 (USD Million)
      • 11.2.1.3 Generics
      • 11.2.1.3.1 Generics market estimates and forecasts, 2016 - 2027 (USD Million)
      • 11.2.1.3.2 Pre-clinical
      • 11.2.1.3.2.1 Pre-clinical market estimates and forecasts, 2016 - 2027 (USD Million)
      • 11.2.1.3.3 Clinical
      • 11.2.1.3.3.1 Clinical market estimates and forecasts, 2016 - 2027 (USD Million)
      • 11.2.1.3.4 PMA
      • 11.2.1.3.4.1 PMA market estimates and forecasts, 2016 - 2027 (USD Million)
    • 11.2.2 Biotechnology companies
      • 11.2.2.1 Biotechnology companies market estimates and forecasts, 2016 - 2027 (USD Million)
      • 11.2.2.2 Biologics
      • 11.2.2.2.1 Biologics market estimates and forecasts, 2016 - 2027 (USD Million)
      • 11.2.2.2.2 Pre-clinical
      • 11.2.2.2.2.1 Pre-clinical market estimates and forecasts, 2016 - 2027 (USD Million)
      • 11.2.2.2.3 Clinical
      • 11.2.2.2.3.1 Clinical market estimates and forecasts, 2016 - 2027 (USD Million)
      • 11.2.2.2.4 PMA
      • 11.2.2.2.4.1 PMA market estimates and forecasts, 2016 - 2027 (USD Million)
      • 11.2.2.3 ATMPs
      • 11.2.2.3.1 ATMPs market estimates and forecasts, 2016 - 2027 (USD Million)
      • 11.2.2.3.2 Pre-clinical
      • 11.2.2.3.2.1 Pre-clinical market estimates and forecasts, 2016 - 2027 (USD Million)
      • 11.2.2.3.3 Clinical
      • 11.2.2.3.3.1 Clinical market estimates and forecasts, 2016 - 2027 (USD Million)
      • 11.2.2.3.4 PMA
      • 11.2.2.3.4.1 PMA market estimates and forecasts, 2016 - 2027 (USD Million)
      • 11.2.2.4 Biosimilar
      • 11.2.2.4.1 Biosimilar market estimates and forecasts, 2016 - 2027 (USD Million)
      • 11.2.2.4.2 Pre-clinical
      • 11.2.2.4.2.1 Pre-clinical market estimates and forecasts, 2016 - 2027 (USD Million)
      • 11.2.2.4.3 Clinical
      • 11.2.2.4.3.1 Clinical market estimates and forecasts, 2016 - 2027 (USD Million)
      • 11.2.2.4.4 PMA
      • 11.2.2.4.4.1 PMA market estimates and forecasts, 2016 - 2027 (USD Million)
    • 11.2.3 Medical device manufacturers
      • 11.2.3.1 Medical device manufacturers market estimates and forecasts, 2016 - 2027 (USD Million)
      • 11.2.3.2 Therapeutic medical devices
      • 11.2.3.2.1 Therapeutic medical devices market estimates and forecasts, 2016 - 2027 (USD Million)
      • 11.2.3.2.2 Pre-clinical
      • 11.2.3.2.2.1 Pre-clinical market estimates and forecasts, 2016 - 2027 (USD Million)
      • 11.2.3.2.3 Clinical
      • 11.2.3.2.3.1 Clinical market estimates and forecasts, 2016 - 2027 (USD Million)
      • 11.2.3.2.4 PMA
      • 11.2.3.2.4.1 PMA market estimates and forecasts, 2016 - 2027 (USD Million)
      • 11.2.3.3 Diagnostic medical devices
      • 11.2.3.3.1 Diagnostic medical devices market estimates and forecasts, 2016 - 2027 (USD Million)
      • 11.2.3.3.2 Pre-clinical
      • 11.2.3.3.2.1 Pre-clinical market estimates and forecasts, 2016 - 2027 (USD Million)
      • 11.2.3.3.3 Clinical
      • 11.2.3.3.3.1 Clinical market estimates and forecasts, 2016 - 2027 (USD Million)
      • 11.2.3.3.4 PMA
      • 11.2.3.3.4.1 PMA market estimates and forecasts, 2016 - 2027 (USD Million)

Chapter 12 Medical Information Market: Regional Estimates & Trend Analysis by Segments

  • 12.1 Regional Market Snapshot
  • 12.2 Market Share Analysis by Country, 2019
    • 12.2.1 North America
    • 12.2.2 Europe
    • 12.2.3 Asia Pacific
    • 12.2.4 Latin America
    • 12.2.5 MEA
  • 12.3 North America
    • 12.3.1 North America Medical information market estimates and forecasts, 2016 - 2027 (USD Million)
    • 12.3.2 The U.S.
      • 12.3.2.1 The U.S. Medical information market estimates and forecasts, 2014 - 2026 ( USD Million)
    • 12.3.3 Canada
      • 12.3.3.1 Canada Medical information market estimates and forecasts, 2014 - 2026 (USD Million)
  • 12.4 Europe
    • 12.4.1 Europe Medical information MARKET estimates and forecasts, 2016 - 2027 (USD Million)
    • 12.4.2 The U.K.
      • 12.4.2.1 The U.K. Medical information market estimates and forecasts, 2014 - 2026 (USD Million)
    • 12.4.3 Germany
      • 12.4.3.1 Germany Medical information market estimates and forecasts, 2016 - 2027 (USD Million)
    • 12.4.4 France
      • 12.4.4.1 France Medical information market estimates and forecasts, 2016 - 2027 (USD Million)
    • 12.4.5 Italy
      • 12.4.5.1 Italy Medical information market estimates and forecasts, 2016 - 2027 (USD Million)
    • 12.4.6 Spain
      • 12.4.6.1 Spain medical information market estimates and forecasts, 2016 - 2027 (USD Million)
  • 12.5 Asia Pacific
    • 12.5.1 Asia Pacific Medical information market estimates and forecasts, 2016 - 2027 (USD Million)
    • 12.5.2 Japan
      • 12.5.2.1 Japan Medical information market estimates and forecasts, 2016 - 2027 (USD Million)
    • 12.5.3 China
      • 12.5.3.1 China Medical information market estimates and forecasts, 2016 - 2027 (USD Million)
    • 12.5.4 India
      • 12.5.4.1 India Medical information market estimates and forecasts, 2016 - 2027 (USD Million)
  • 12.6 Latin America
    • 12.6.1 Latin America Medical information market estimates and forecasts, 2016 - 2027 (USD Million)
    • 12.6.2 Brazil
      • 12.6.2.1 Brazil Medical information market estimates and forecasts, 2016 - 2027 (USD Million)
    • 12.6.3 Mexico
      • 12.6.3.1 Mexico Medical information market estimates and forecasts, 2016 - 2027 (USD Million)
  • 12.7 MEA
    • 12.7.1 MEA Medical information market estimates and forecasts, 2016 - 2027 (USD Million)
    • 12.7.2 South Africa
      • 12.7.2.1 South Africa Medical information market estimates and forecasts, 2016 - 2027 (USD Million)
    • 12.7.3 Saudi Arabia
      • 12.7.3.1 Saudi Arabia Medical information market estimates and forecasts, 2016 - 2027 (USD Million)

Chapter 13 Company Profiles

  • 13.1 McKesson Corporation
    • 13.1.1 Company overview
    • 13.1.2 Financial performance
    • 13.1.3 R&D expenditure
    • 13.1.4 Geographic foothold
    • 13.1.5 Organization structure & Team Composition
      • 13.1.5.1 Team composition
    • 13.1.6 Platform benchmarking
    • 13.1.7 Strategic initiatives
    • 13.1.8 SWOT Analysis
  • 13.2 Parexel International Corporation
    • 13.2.1 Company overview
    • 13.2.2 Financial performance
    • 13.2.3 Organization structure & Team Composition
      • 13.2.3.1 Team composition
    • 13.2.4 Platform benchmarking
    • 13.2.5 Strategic initiatives
    • 13.2.6 SWOT Analysis
  • 13.3 IQVIA
    • 13.3.1 Company overview
    • 13.3.2 Financial performance
    • 13.3.3 Geographic foothold
    • 13.3.4 Organization structure & Team Composition
      • 13.3.4.1 Team composition
    • 13.3.5 Platform benchmarking
    • 13.3.6 Strategic initiatives
    • 13.3.7 SWOT Analysis
  • 13.4 C3i Solutions, HCL Technologies Company
    • 13.4.1 Company overview
    • 13.4.2 Financial performance
    • 13.4.3 R&D expenditure
    • 13.4.4 Geographic foothold
    • 13.4.5 Organization structure & Team Composition
      • 13.4.5.1 Team composition
    • 13.4.6 Platform benchmarking
    • 13.4.7 Strategic initiatives
    • 13.4.8 SWOT Analysis
  • 13.5 PrimeVigilance
    • 13.5.1 Company overview
    • 13.5.2 Financial performance
    • 13.5.3 R&D expenditure
    • 13.5.4 Geographic foothold
    • 13.5.5 Organization structure & Team Composition
      • 13.5.5.1 Team composition
    • 13.5.6 Platform benchmarking
    • 13.5.7 Strategic initiatives
    • 13.5.8 SWOT Analysis
  • 13.6 ProPharma Group
    • 13.6.1 Company overview
    • 13.6.2 Financial performance
    • 13.6.3 Organization structure & Team Composition
      • 13.6.3.1 Team composition
    • 13.6.4 Platform benchmarking
    • 13.6.5 Strategic initiatives
    • 13.6.6 SWOT Analysis
  • 13.7 Accenture
    • 13.7.1 Company overview
    • 13.7.2 Financial performance
    • 13.7.3 R&D expenditure
    • 13.7.4 Geographic foothold
    • 13.7.5 Organization structure & Team Composition
      • 13.7.5.1 Team composition
    • 13.7.6 Platform benchmarking
    • 13.7.7 Strategic initiatives
    • 13.7.8 SwOT Analysis
  • 13.8 Cognizant
    • 13.8.1 Company overview
    • 13.8.2 Financial performance
    • 13.8.3 Geographic foothold
    • 13.8.4 Organization structure & Team Composition
      • 13.8.4.1 Team composition
    • 13.8.5 Platform benchmarking
    • 13.8.6 Strategic initiatives
    • 13.8.7 SWOT Analysis
  • 13.9 Infosys Limited
    • 13.9.1 Company overview
    • 13.9.2 Financial performance
    • 13.9.3 R&D expenditure
    • 13.9.4 Geographic foothold
    • 13.9.5 Organization structure & Team Composition
      • 13.9.5.1 Team composition
    • 13.9.6 Platform benchmarking
    • 13.9.7 Strategic initiatives
    • 13.9.8 SWOT Analysis
  • 13.10 PharmCentre
    • 13.10.1 Company overview
    • 13.10.2 Financial performance
    • 13.10.3 Organization structure & Team Composition
      • 13.10.3.1 Team composition
    • 13.10.4 Platform benchmarking
    • 13.10.5 Strategic initiatives
    • 13.10.6 SWOT Analysis

Chapter 14 Winning Strategies

  • 14.1 Key Winning/Scoring Criteria
    • 14.1.1 By categories
      • 14.1.1.1 Pharmaceuticals
      • 14.1.1.2 Biotechnology companies
      • 14.1.1.3 Medical device companies
  • 14.2 Key Vendor Selection Factors
    • 14.2.1 By Category
    • 14.2.2 BY Company size
      • 14.2.2.1 by geographies

Chapter 15 Switching Cost Analysis

Chapter 16 Covid-19 Impact Analysis

  • 16.1 Current And Future Impact Analysis
  • 16.2 Covid-19 Opportunity Analysis
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.